CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $15,000 | -42.3% | 12,535 | -13.4% | 0.00% | – |
Q2 2022 | $26,000 | -60.6% | 14,476 | -55.8% | 0.00% | – |
Q1 2022 | $66,000 | -57.7% | 32,732 | -43.2% | 0.00% | -100.0% |
Q4 2021 | $156,000 | -53.6% | 57,600 | +15.4% | 0.00% | -50.0% |
Q2 2020 | $336,000 | -55.8% | 49,894 | -74.2% | 0.00% | -33.3% |
Q3 2019 | $760,000 | -69.9% | 193,388 | +14.1% | 0.00% | -66.7% |
Q2 2019 | $2,521,000 | -39.4% | 169,524 | +1.2% | 0.01% | -43.8% |
Q1 2019 | $4,158,000 | -29.2% | 167,524 | -48.8% | 0.02% | -38.5% |
Q4 2018 | $5,877,000 | +126.0% | 327,270 | +269.5% | 0.03% | +188.9% |
Q3 2018 | $2,601,000 | -63.8% | 88,573 | -43.9% | 0.01% | -70.0% |
Q2 2018 | $7,183,000 | – | 157,968 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |